ADM’s new $30 million facility in Spain will produce probiotics and postbiotics

Published on: 

The facility enables a five-fold increase in production capacity, increasing it to 50 metric tons per year.

ADM (Chicago) has opened a new $30 million facility in Spain to produce ingredients like probiotics, postbiotics, and other health and wellness ingredients. The company says the facility enables a five-fold increase in its production capacity for ingredients like probiotics and postbiotics, increasing it to 50 metric tons per year.

“The facility will allow ADM to supply growing markets for probiotics and postbiotics in the U.S., Asia-Pacific, and Europe,” the company’s press release states. “ADM expects its customer base will more than triple over the next five years as more people recognize the links between the gut microbiome and many aspects of health and look for products tailored to their specific needs.”

The company says this is the world’s first facility to produce both probiotics and postbiotics at the same site. The facility will produce the company’s award-winning probiotic ingredient BPL1 as well as its heat-treated BPL1 postbiotic ingredient, plus other strains proprietary to ADM.

“It will also be able to support further growth in ADM’s UK-leading Bio-Kult brand of products,” the press release adds. “The new facility is located close to ADM’s pioneering research and development center in the University of Valencia Scientific Park where ADM scientists undertake activity including next-generation genome sequencing and early-stage testing of new bacterial strains.”